4SC
Europe, Bayern, Germany, Planegg
Description
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases.
Investor Profile
4SC has made 1 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Seed (100%)
Country Focus
- Austria (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
